Share on StockTwits

Solazyme (NASDAQ:SZYM) Director Michael V. Arbige sold 1,000 shares of the stock in a transaction that occurred on Monday, June 16th. The shares were sold at an average price of $11.34, for a total transaction of $11,340.00. Following the completion of the sale, the director now directly owns 132,787 shares in the company, valued at approximately $1,505,805. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Solazyme (NASDAQ:SZYM) traded up 6.17% on Monday, hitting $12.04. 1,812,630 shares of the company’s stock traded hands. Solazyme has a one year low of $8.00 and a one year high of $15.00. The stock has a 50-day moving average of $10.04 and a 200-day moving average of $10.78. The company’s market cap is $914.7 million.

Solazyme (NASDAQ:SZYM) last released its earnings data on Monday, May 5th. The company reported ($0.44) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.33) by $0.11. The company had revenue of $12.40 million for the quarter, compared to the consensus estimate of $14.63 million. During the same quarter in the prior year, the company posted ($0.43) earnings per share. The company’s quarterly revenue was up 85.1% on a year-over-year basis. Analysts expect that Solazyme will post $-1.56 EPS for the current fiscal year.

A number of analysts have recently weighed in on SZYM shares. Analysts at Morgan Stanley reiterated an “overweight” rating on shares of Solazyme in a research note on Friday, May 30th. They now have a $15.00 price target on the stock. Separately, analysts at Credit Suisse cut their price target on shares of Solazyme from $12.00 to $11.00 in a research note on Wednesday, April 2nd. Finally, analysts at Cowen and Company raised their price target on shares of Solazyme from $17.00 to $18.00 in a research note on Tuesday, April 1st. One analyst has rated the stock with a sell rating, one has issued a hold rating and two have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $15.00.

Solazyme, Inc operates as a renewable oil production company. The Company fuels include microbial-derived jet fuels, bio-diesels, and renewable diesels.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.